Valeritas announces the brand name V-Go™ for their disposable insulin delivery device which utilizes the
h-Patch™ technology for continuous insulin delivery
|
The V-Go™ is a simple-to-use, once-daily, disposable insulin delivery device that provides a continuous set basal rate and on-demand bolus dosing for mealtime coverage via a rapid acting insulin analog. The V-Go™ will enable the millions suffering from Type 2 diabetes to discreetly and conveniently deliver insulin throughout the day and on-demand dosing around mealtimes. Developed to help enhance a patient's glycemic control and improve compliance, the V-Go™ is the smallest known FDA-cleared insulin delivery device with basal-bolus capability and no visible needle. The V-Go™ has received FDA 510(k) clearance and Phase IV clinical trials are in development to support broad marketing and reimbursement claims. The h-Patch™ technology also being developed to serve as a launching platform for applications across a wide spectrum of medical needs.
|
 |
